NHS National Framework Agreement for the Supply of Lanadelumab

NHS EnglandcontractContracts FinderRef tender_219286/826226SME suitablecomplete
View buyer

Estimated value

£4.8m

Awarded value

£4.8m

Awarded 18 Dec 2019

Suppliers

1

Lots

1

1 awarded

Published

07 Jan 2020

Deadline 05 Nov 2019

Other contracts from NHS England· 10

Most recent notices published by the same contracting authority.

View buyer profile →
TitleTypeValuePublished
Matrix - Desk Booking Systemcall off£105k08 May 2026
Telephony 0300 Numbers Renewal (Gamma) 2026 - 2028call off£17k08 May 2026
ID&V Checking Servicecontract£150k08 May 2026
Xerox Managed Print renewal 26/27call off£127k08 May 2026
Manage Engine ServiceDesk Plus Licencescall off£29k08 May 2026
Ccube EDRMS C302203 Annual Maintenance and Support 2025 - 2026contract£105k08 May 2026
Clinicals Run Maintain Transformcall off£38.0m10 Apr 2026
Specialised Pharmaceutical Logistics and Warehouse Services for Vaccination & Immunisation Programmescontract07 Apr 2026
NHS England procurement for the supply of Pan-genotypic Direct Acting Antiviral (DAA) Hepatitis C treatments and the provision of Hepatitis C elimination initiativescontract07 Apr 2026
CPIT System Integration to NHSE RAVScontract£500k01 Apr 2026

Other contracts awarded to Shire Pharmaceuticals Ltd· 9

Cross-buyer view of this supplier's public-sector wins.

View supplier profile →
TitleTypeValuePublished
Human Normal Immunoglobulin and Anti-D Immunoglobulincontract£64.3m23 Jul 2021
Medicinal Products and Pharma Funded Homecare Servicescontract23 Jul 2021
NHS Framework Agreement for the supply of Human Normal Immunoglobulin and Anti-D Immunoglobulincontract22 Jul 2021
Recombinant Von Willebrand Factorcontract£250k22 Feb 2021
NHS National Framework Agreement for the Supply of Recombinant Von Willebrand Factorcontract27 Jan 2021
NHS National Framework Agreement for the supply of products for the treatment of Haemophilia Acall off£37.2m03 Jul 2020
NHS Framework Agreement for the supply of Recombinant Factor IX products for the treatment of Haemophilia Bcontract£38.4m25 Mar 2019
NHS Framework Agreement for the supply of Icatibant and C1 Esterase products for the treatment of Hereditary Angioedemacall off£24.0m16 Jul 2018
NHS National Framework agreement for the supply of Homecare Delivery Service - Products for the treatment of bleeding disorders in England, Wales and Northern Irelandcall off£1.6m25 Jun 2018